AMN HEALTHCARE SERVICES INC (AMN)
US0017441017 - Common Stock
We assign a fundamental rating of 5 out of 10 to AMN. AMN was compared to 108 industry peers in the Health Care Providers & Services industry. AMN has an excellent profitability rating, but there are some minor concerns on its financial health. AMN has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
In the past year AMN was profitable.
In the past year AMN had a positive cash flow from operations.
In the past 5 years AMN has always been profitable.
Each year in the past 5 years AMN had a positive operating cash flow.
1.2 Ratios
AMN has a Return On Assets of 1.99%. This is in the better half of the industry: AMN outperforms 64.49% of its industry peers.
The Return On Equity of AMN (5.96%) is better than 67.29% of its industry peers.
AMN's Return On Invested Capital of 4.59% is in line compared to the rest of the industry. AMN outperforms 57.01% of its industry peers.
AMN had an Average Return On Invested Capital over the past 3 years of 17.26%. This is significantly above the industry average of 8.15%.
The last Return On Invested Capital (4.59%) for AMN is well below the 3 year average (17.26%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.99% | ||
| ROE | 5.96% | ||
| ROIC | 4.59% |
ROA(3y)11.01%
ROA(5y)8.39%
ROE(3y)32.02%
ROE(5y)24.03%
ROIC(3y)17.26%
ROIC(5y)13.59%
1.3 Margins
Looking at the Profit Margin, with a value of 1.73%, AMN is in the better half of the industry, outperforming 64.49% of the companies in the same industry.
In the last couple of years the Profit Margin of AMN has declined.
Looking at the Operating Margin, with a value of 4.37%, AMN is in the better half of the industry, outperforming 61.68% of the companies in the same industry.
In the last couple of years the Operating Margin of AMN has remained more or less at the same level.
AMN's Gross Margin of 31.34% is in line compared to the rest of the industry. AMN outperforms 57.01% of its industry peers.
In the last couple of years the Gross Margin of AMN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.37% | ||
| PM (TTM) | 1.73% | ||
| GM | 31.34% |
OM growth 3Y1.49%
OM growth 5Y-1.21%
PM growth 3Y23.47%
PM growth 5Y-3.47%
GM growth 3Y-0.1%
GM growth 5Y0.23%
2. Health
2.1 Basic Checks
AMN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for AMN has been reduced compared to 1 year ago.
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
AMN has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.44 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score (2.44) which is comparable to the rest of the industry.
AMN has a debt to FCF ratio of 10.26. This is a negative value and a sign of low solvency as AMN would need 10.26 years to pay back of all of its debts.
The Debt to FCF ratio of AMN (10.26) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.27 is on the high side and indicates that AMN has dependencies on debt financing.
AMN has a worse Debt to Equity ratio (1.27) than 68.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 10.26 | ||
| Altman-Z | 2.44 |
ROIC/WACC0.72
WACC6.35%
2.3 Liquidity
AMN has a Current Ratio of 1.18. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.18, AMN is doing worse than 66.36% of the companies in the same industry.
A Quick Ratio of 1.18 indicates that AMN should not have too much problems paying its short term obligations.
The Quick ratio of AMN (1.18) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -58.37% in the last year.
Measured over the past years, AMN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.92% on average per year.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.12%.
The Revenue has been growing by 12.15% on average over the past years. This is quite good.
EPS 1Y (TTM)-58.37%
EPS 3Y33.37%
EPS 5Y19.92%
EPS Q2Q%-69.04%
Revenue 1Y (TTM)-25.12%
Revenue growth 3Y16.55%
Revenue growth 5Y12.15%
Sales Q2Q%-19.44%
3.2 Future
Based on estimates for the next years, AMN will show a decrease in Earnings Per Share. The EPS will decrease by -0.91% on average per year.
Based on estimates for the next years, AMN will show a decrease in Revenue. The Revenue will decrease by -1.97% on average per year.
EPS Next Y-62.44%
EPS Next 2Y-54.99%
EPS Next 3Y-32.79%
EPS Next 5Y-0.91%
Revenue Next Year-21.97%
Revenue Next 2Y-15.68%
Revenue Next 3Y-9.12%
Revenue Next 5Y-1.97%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 5.99, the valuation of AMN can be described as very cheap.
99.07% of the companies in the same industry are more expensive than AMN, based on the Price/Earnings ratio.
AMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
AMN is valuated correctly with a Price/Forward Earnings ratio of 14.05.
AMN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AMN is cheaper than 76.64% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.73. AMN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.99 | ||
| Fwd PE | 14.05 |
4.2 Price Multiples
AMN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMN is cheaper than 91.59% of the companies in the same industry.
AMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMN is cheaper than 91.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.02 | ||
| EV/EBITDA | 6.38 |
4.3 Compensation for Growth
AMN has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as AMN's earnings are expected to decrease with -32.79% in the coming years.
PEG (NY)N/A
PEG (5Y)0.3
EPS Next 2Y-54.99%
EPS Next 3Y-32.79%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMN HEALTHCARE SERVICES INC
NYSE:AMN (12/23/2024, 11:31:14 AM)
23.225
+0.29 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners117.49%
Inst Owner Change0.89%
Ins Owners0.36%
Ins Owner Change2.46%
Market Cap884.18M
Analysts69.23
Price Target42.11 (81.31%)
Short Float %10.78%
Short Ratio3.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.69%
Min EPS beat(2)5.34%
Max EPS beat(2)28.04%
EPS beat(4)4
Avg EPS beat(4)9.54%
Min EPS beat(4)0.39%
Max EPS beat(4)28.04%
EPS beat(8)8
Avg EPS beat(8)10.81%
EPS beat(12)12
Avg EPS beat(12)10.19%
EPS beat(16)16
Avg EPS beat(16)12.66%
Revenue beat(2)1
Avg Revenue beat(2)0.21%
Min Revenue beat(2)-0.96%
Max Revenue beat(2)1.38%
Revenue beat(4)2
Avg Revenue beat(4)0.21%
Min Revenue beat(4)-0.96%
Max Revenue beat(4)1.38%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)8
Avg Revenue beat(12)1.17%
Revenue beat(16)11
Avg Revenue beat(16)2.26%
PT rev (1m)-24.54%
PT rev (3m)-37.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.63%
EPS NY rev (1m)-2.97%
EPS NY rev (3m)-3.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.69%
Revenue NY rev (1m)1.12%
Revenue NY rev (3m)1.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.99 | ||
| Fwd PE | 14.05 | ||
| P/S | 0.29 | ||
| P/FCF | 8.02 | ||
| P/OCF | 4.28 | ||
| P/B | 0.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.38 |
EPS(TTM)3.88
EY16.71%
EPS(NY)1.65
Fwd EY7.12%
FCF(TTM)2.89
FCFY12.46%
OCF(TTM)5.42
OCFY23.35%
SpS80.57
BVpS23.4
TBVpS-16.51
PEG (NY)N/A
PEG (5Y)0.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.99% | ||
| ROE | 5.96% | ||
| ROCE | 6.24% | ||
| ROIC | 4.59% | ||
| ROICexc | 4.66% | ||
| ROICexgc | 16.47% | ||
| OM | 4.37% | ||
| PM (TTM) | 1.73% | ||
| GM | 31.34% | ||
| FCFM | 3.59% |
ROA(3y)11.01%
ROA(5y)8.39%
ROE(3y)32.02%
ROE(5y)24.03%
ROIC(3y)17.26%
ROIC(5y)13.59%
ROICexc(3y)18.1%
ROICexc(5y)14.21%
ROICexgc(3y)63.19%
ROICexgc(5y)49.77%
ROCE(3y)23.43%
ROCE(5y)18.46%
ROICexcg growth 3Y6.33%
ROICexcg growth 5Y0.89%
ROICexc growth 3Y12.07%
ROICexc growth 5Y-2.64%
OM growth 3Y1.49%
OM growth 5Y-1.21%
PM growth 3Y23.47%
PM growth 5Y-3.47%
GM growth 3Y-0.1%
GM growth 5Y0.23%
F-Score5
Asset Turnover1.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 10.26 | ||
| Debt/EBITDA | 3.65 | ||
| Cap/Depr | 54.87% | ||
| Cap/Sales | 3.14% | ||
| Interest Coverage | 2.19 | ||
| Cash Conversion | 66.71% | ||
| Profit Quality | 207.78% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 2.44 |
F-Score5
WACC6.35%
ROIC/WACC0.72
Cap/Depr(3y)58.76%
Cap/Depr(5y)56.04%
Cap/Sales(3y)1.89%
Cap/Sales(5y)1.79%
Profit Quality(3y)110.83%
Profit Quality(5y)161.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-58.37%
EPS 3Y33.37%
EPS 5Y19.92%
EPS Q2Q%-69.04%
EPS Next Y-62.44%
EPS Next 2Y-54.99%
EPS Next 3Y-32.79%
EPS Next 5Y-0.91%
Revenue 1Y (TTM)-25.12%
Revenue growth 3Y16.55%
Revenue growth 5Y12.15%
Sales Q2Q%-19.44%
Revenue Next Year-21.97%
Revenue Next 2Y-15.68%
Revenue Next 3Y-9.12%
Revenue Next 5Y-1.97%
EBIT growth 1Y-68.35%
EBIT growth 3Y18.28%
EBIT growth 5Y10.78%
EBIT Next Year-20.27%
EBIT Next 3Y-12.37%
EBIT Next 5YN/A
FCF growth 1Y-79.79%
FCF growth 3Y7.01%
FCF growth 5Y6.96%
OCF growth 1Y-66.5%
OCF growth 3Y13.17%
OCF growth 5Y10.39%